Tag: Insilico Medicine

An AI-Designed Drug Is Moving Toward Approval at an Impressive Clip

Insilico Medicine, a biotechnology company based in New York and Hong Kong, has developed an AI-designed drug, ISM018_055, targeting idiopathic pulmonary fibrosis, a fatal lung disease. The drug has entered Phase II clinical trials, marking a milestone in drug discovery. Insilico utilized AI throughout the drug’s development process with their Pharma.AI platform, significantly accelerating the […]

DAILY LINKS TO YOUR INBOX

PROMPT ENGINEERING

Prompt Engineering Guides

ShareGPT

 

©2024 The Horizon